Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food recall warning - Venetian Meats brand Finocchiona Salami Sweet Fennel recalled due to Salmonella


Product photos are available

OTTAWA, ON, Dec. 22, 2022 /CNW/ -

Summary

Brand(s)
Venetian Meats
Product
Finocchiona Salami Sweet Fennel
Issue
Food - Microbial Contamination - Salmonella
What to do
Do not consume, use, sell, serve, or distribute recalled products.

Affected products

Brand

Product

Size

UPC

Codes

Venetian Meats

Finocchiona Salami Sweet Fennel

2 kg

None

All Best Before Dates bearing Lot 242

Issue

The affected product is being recalled from the marketplace due to possible Salmonella contamination.

The recalled product has been sold in British Columbia, Alberta, Manitoba and Ontario.

What you should do

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Learn more:

Additional information

Previous recalls or alerts
Venetian Meats brand Finocchiona Salami Sweet Fennel recalled due to Salmonella

Background

This recall was triggered by test results.

There have been no reported illnesses associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

Category
Food - Meat and poultry - Processed
Companies
Venetian Meat & Salami Co. Ltd.

Audience
General public
Recall class
Class 2

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...



News published on and distributed by: